Abstract:Bacteriophages (phages) were discovered in the early part of the 20th century, and their ability to eliminate bacterial infections as bacterial viruses gathered interest almost immediately. Bacteriophage therapy was halted in the Western world due to inconclusive results in early experiments and the concurrent discovery of antibiotics. The spread of antibiotic-resistant bacteria has elicited renewed interest in bacteriophages as a natural alternative to conventional antibiotic therapy. Interest in the application of bacteriophages has also expanded to include the environment, such as wastewater treatment, agriculture and aquaculture. Although the complete phage is important in bacteriophage therapy, the focus is shifting to purified phage enzymes. These enzymes are an attractive option for pharmaceutical companies with their patent potential. They can be bio-engineered for enhanced adjuvant properties, such as a broadened spectrum of activity or binding capability. Enzymes also eliminate the concern that the prophage might integrate resistance genes into the bacterial genome. From a clinical perspective, the first randomised clinical controlled phage therapy trial was conducted with more pioneering phase I/II clinical studies on the horizon. In this opinion paper, the authors outline bacteriophages as naturally occurring bactericidal entities, their therapeutic potential against antibiotic-resistant bacteria and compare them to antibiotics. Their potential multipurpose application in the medical field is also addressed, including the use of bacteriophages for vaccination, and utilisation of the antimicrobial enzymes that they produce.

A century of the phage: past, present and future

Phage-Enabled Nanomedicine: from Probes to Therapeutics in Precision Medicine.

Bacteriophages: biology and history

Bacteriophages and their genomes

Phages and Human Health: More Than Idle Hitchhikers

Phage therapy: From biological mechanisms to future directions

Bacteriophage Technology and Modern Medicine

Advance on Engineering of Bacteriophages by Synthetic Biology

Making the leap from technique to treatment - genetic engineering is paving the way for more efficient phage therapy

A Bioinformatic Ecosystem for Bacteriophage Genomics: PhaMMSeqs, Phamerator, pdm_utils, PhagesDB, DEPhT, and PhamClust

Genetic Engineering of Bacteriophages Against Infectious Diseases

Phage diversity, genomics and phylogeny

Exploring the Potential of Bacteriophages on Earth and Beyond

Bacteriophage-Based Bioanalysis

Bacteriophages and its applications: an overview

RNA and Single-Stranded DNA Phages: Unveiling the Promise from the Underexplored World of Viruses

Exploring the transcriptional landscape of phage–host interactions using novel high-throughput approaches

Treating bacterial infections with bacteriophages in the 21st century

Phage therapy gets revitalized

Current and future directions in bacteriophage research for developing therapeutic innovations

Bacteriophages: Protagonists of a Post-Antibiotic Era